News ADC Therapeutics SA

Equities

ADCT

CH0499880968

Market Closed - Nyse Other stock markets 21:00:02 26/04/2024 BST			5-day change	1st Jan Change
4.34 ^USD	-2.25%		-8.05%	+161.45%

04-09	Transcript : ADC Therapeutics SA - Special Call
04-04	Sector Update: Health Care Stocks Slump Late Afternoon	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : ADC Therapeutics SA - Special Call	04-09
ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed, Refractory B-cell Non-Hodgkin Lymphoma	04-05	AQ
Sector Update: Health Care Stocks Slump Late Afternoon	04-04	MT
ADC Therapeutics Shares Rise After Completion of Dose Escalation Part of Phase 1b Lymphoma Trial	04-04	MT
ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma	04-04	GL
ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024	04-03	GL
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	04-01	GL
Chiome Bioscience Cancels License Agreements with ADC Therapeutics	04-01	MT
Guggenheim Initiates ADC Therapeutics With Buy Rating, $11 Price Target	03-28	MT
Transcript : ADC Therapeutics SA, Q4 2023 Earnings Call, Mar 13, 2024	03-13
ADC Therapeutics SA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-13	CI
ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	03-13	GL
ADC Therapeutics SA Reports Earnings Results for the Full Year Ended December 31, 2023	03-13	CI
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting	03-06	AQ
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit	03-06	GL
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit	03-06	AQ
ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024	03-06	GL
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting	03-05	GL
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting	03-05	AQ
ADC Therapeutics : TD Cowen Healthcare Conference	03-05	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ADC Therapeutics SA

Equities

ADCT

CH0499880968

Summary

Filters